Suneva Medical and Viveon Health Acquisition announced today that they have entered into a definitive merger agreement. If approved, upon completion of the transaction the combined company’s securities are expected to be traded on the NYSE under the symbol “RNEW.”
The pro forma equity valuation (assuming no share redemptions) of the combined company is expected to be approximately $511 million.
VHAQ raised approximately $201 million in its IPO.
Under the terms of the proposed transaction, VHAQ will issue 25 million shares to current security holders of Suneva. Suneva stockholders may also receive up to 12 million earn out shares if certain stock price thresholds are met.
Suneva is headquartered in San Diego, CA, and develops regenerative aesthetics solutions. Read more.
